PTGX Announces Fast Track Designation by U.S. FDA Alış

Protagonist Therapeutics, Inc.NASDAQ

Açıklama

⋅ 27 Eyl 2018 16:53

Protagonist Therapeutics Announces Fast Track Designation Granted by U.S. FDA to Hepcidin Mimetic PTG-300